Update on Brazil's pharma patent landscape.
Brazil's Pharma market is a dynamic and promising one. It ranks within the top ten market. There are peculiar hurdles that patentees have to overcome, such as, a two-tier examination, a serious backlog at the Brazilian Patent and Trademark Office. Several measures to accelerate examination have been adopted given the meager number of Examiners.
Daniel Advogados, Av. República do Chile, 230 - 3º Andar, Centro Rio de Janeiro, RJ, Brasil, Rio de Janeiro 20031-170, Brazil.
Rana
R
Gosain
D044822:Biodiversity; D001938:Brazil; D002986:Clinical Trials as Topic / Q000592:standards; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
ANVISA; Brazil; PPH; backlog; biodiversity; clinical trials; generics; mailbox litigation; pharmaceutical market